Astellas Pharma (Germany)

Astellas Pharma (Germany)

Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Astellas Pharma (Germany), Germany, covering academic research published from 2006 to 2024. Read More.


Open Access Percentage

49%


Total
Publications

51


Total Open
Publications

25


Total
Citations

1.4K


Open Access
Percentage

49%


Total
Publications

51


Total Open
Publications

25


Total
Citations

1.4K

Wikipedia

Website

download

Breakdown

18% 25% 6% 51%

Publisher Open

18%

Both

25%

Other Platform Open

6%

Closed

51%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

00.511.522.533.544.555.566.57Total Publications
2006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

23%OA Journal

OA Journal 23%

5

Hybrid 59%

13

No Guarantees 18%

4

Other Platform Open

Institution 50%

8

Domain 50%

8

Other Internet 13%

2

Public 6%

1

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
8
DANS - Data Archiving and Networked Services
Institution
2
Unknown Repository
Other Internet
1
University of Bristol - Bristol Research
Institution
1
Universidade Federal de São Paulo - UNIFESP Institutional Repository
Institution
1
TESEO - Consultation of the Doctoral Thesis Database
Institution
1
Servicio Gallego de Salud (SERGAS - RUNA. Repositorio Institucional del Sergas)
Institution
1
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
1
Konstfack University of Arts, Crafts, and Design - Publications
Institution
1
Figshare
Public
1
1 / 2

Data updated 18 August 2025

Share

Share

Share